- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1373
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1373 companies
NexImmune
Market Cap: US$13.9k
A clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States.
NEXI
US$0.0001
7D
-99.0%
1Y
-100.0%
eFFECTOR Therapeutics
Market Cap: US$2.4k
A biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer.
EFTR
US$0.0002
7D
0%
1Y
-99.6%
Telesis Bio
Market Cap: US$1.8k
A synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.
TBIO
US$0.012
7D
1,130.0%
1Y
-99.5%
OpGen
Market Cap: US$1.0k
A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
OPGN
US$0.0001
7D
0%
1Y
-100.0%
Affimed
Market Cap: US$16.0
A clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany.
AFMD.Q
US$0.0001
7D
0%
1Y
-100.0%